Orca Bio’s TREGZI™ Receives U.S. FDA Approval as First and Only Precision-Engineered Cell Therapy for Allogeneic Transplant in Adults with Hematological Malignancies

Company About Us Leadership Approach High-Precision Technology Manufacturing Therapies Pipeline Orca-T Orca-Q Scientific Publications Expanded Access Policy Patients & Families Our Purpose Key Terms More Resources Culture & Careers Who We Are Open Positions Newsroom Company About Us Leadership Approach High-Precision Technology Manufacturing Therapies Pipeline Orca-T Orca-Q Scientific Publications Expanded Access Policy Patients & Families […] The post Orca Bio’s TREGZI™ Receives U.S. FDA Approval as First and Only Precision-Engineered Cell Therapy for Allogeneic Transplant in Adults with Hema